NCT06971991View on ClinicalTrials.gov

qDSA Blood Flow Measurement in Patients Undergoing TAE of the Liver

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 13, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Transarterial EmbolismTransarterial Chemoembolization
Interventions
DEVICE

qDSA Blood Flow Measurement

The research intervention is limited to several additional qDSA image acquisitions, which include administration of additional iodinated contrast medium.

Trial Locations (1)

53792

RECRUITING

UW Hospital and Clinics, Madison

All Listed Sponsors
collaborator

Siemens Medical Solutions

INDUSTRY

lead

University of Wisconsin, Madison

OTHER